Biopreservation Media Storage Equipment Market Size, Share and Trends 2026 to 2035
Biopreservation Media Storage Equipment Market (By Product Type: Cryopreservation Equipment, Controlled-Rate Freezers, Liquid Nitrogen Storage Tanks, Others; By Application: Research & Development, Clinical Applications, Commercial Applications.; By End-Use: Healthcare, Biotechnology, Academic Research) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035
Get a Sample
Table Of Content
What is the Biopreservation Media Storage Equipment Market Size in 2026?
The global biopreservation media storage equipment market size was calculated at USD 1.30 billion in 2025 and is predicted to increase from USD 1.40 billion in 2026 to approximately USD 2.69 billion by 2035, expanding at a CAGR of 7.55% from 2026 to 2035. The market is poised for robust growth, driven by the increasing need for effective preservation methods in the biotechnology and pharmaceutical sectors. Technological advancements and rising investments in biobanking and academia are further propelling market expansion.
Key Takeaways
- North America dominated the global biopreservation media storage equipment market in 2025.
- Asia-Pacific is expected to grow at the fastest CAGR in the market during the forecast period.
- By product type, the cryopreservation equipment segment held a dominant position in the market in 2025.
- By product type, the controlled-rate freezers segment is expected to grow at the fastest CAGR in the market between 2026 and 2035.
- By application, the research and development segment led the global market in 2025
- By application, the clinical applications segment is expected to grow with the highest CAGR in the market during the studied years.
- By end-use, the healthcare segment dominated the global market in 2025.
- By end-use, the biotechnology segment is expected to expand rapidly in the market in the coming years.
Biopreservation Media Storage Equipment: Biological Integrity Protection
The biopreservation media storage equipment market is a growing industry owing to the increased demand for biobanking, regenerative medicine, and vaccine storage. The growing number of clinical research activities and cell-based therapies is increasing the demand of an efficient system of storage at ultralow temperature. Demand is further facilitated by the growth of blood banks, fertility clinics, and pharmaceutical R&D. The cold chain infrastructure and automation of laboratories through technological improvement are further boosting the market growth.
How AI is Influencing Biopreservation Media Storage Equipment?
Artificial intelligence (AI) revolutionizes the biopreservation media storage equipment industry by enabling predictive temperature monitoring and automated diagnostics. AI-driven sensors identify deviations in performance on a real-time basis, eliminating the risk of loss of samples. AI-based sensors can facilitate digital displays, indicating the presence of several samples, storage conditions, temperature, and potential sample defects. The smart inventory management system streamlines the use of the storage space and the monitoring of biological samples. Moreover, AI-based analytics improves energy efficiency and preventive maintenance measures at laboratory and bio bank facilities.
Biopreservation Media Storage Equipment Market Trends
- Robotization and Intelligent Warehousing: Operational effectiveness is being enhanced by automated sample retrieval systems and digital monitoring platforms in biobanks and laboratories.
- Sustainability and Energy-Efficiency: Companies are producing energy-efficient compressors, generally friendly refrigerants, and low-power freezers to lessen the environmental impact.
- Technological Advances in Cryopreservation: The development of improved cryogenic preservation methods is improving the long-term stability of cells, tissues, and biological specimens.
- Ultra-Low Temperature Freezers: The increasing need for -80 °C and lower freezers is the consequence of the necessity for storing vaccines, research in gene therapy, and biopharmaceutical creation.
Market Scope
| Report Coverage | Details |
| Market Size in 2025 | USD 1.30 Billion |
| Market Size in 2026 | USD 1.40 Billion |
| Market Size by 2035 | USD 2.69 Billion |
| Market Growth Rate from 2026 to 2035 | CAGR of 7.55% |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Product Type, Application,End-Use, and region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Segmental Insights
Product Type Insights
Why Did the Cryopreservation Equipment Segment Dominate the Market?
The cryopreservation equipment dominated the biopreservation media storage equipment market in 2025, due to its critical role in long-term storage of cells, tissues, blood products, and reproductive samples. Such systems are ultra-low temperature freezers and liquid nitrogen storage tanks that are common in biobanks and hospitals. Regenerative medicine and stem cell therapies have high levels of adoption due to increasing demand. Research on pharmaceuticals and vaccines should also raise the dependency on dependable cryogenic systems. Ongoing new developments in temperature stability and monitoring technology support segment leadership.
The controlled-rate freezers segment is expected to show the fastest growth over the forecast period, as they offer an accurate temperature drop to preserve cell viability in the freezing process. Controlled-rate freezers find extensive application in cell and gene therapy with requirements on sample integrity. The increasing number of clinical trials in regenerative medicine promotes the need for sophisticated freezing procedures. Programmable cooling profiles and automation increase efficiency and reproducibility. Due to the increased biotechnology research globally, the implementation of such systems is hastening.
Application Insights
Which Application Segment Dominated the Biopreservation Media Storage Equipment Market?
The research and development segment contributed the biggest market share in 2025, because of the rising research initiatives in the biomedical and pharmaceutical business. Pharmaceutical firms, CROs, and academic institutes need to have secure storage of biological samples. The increasing genomics, proteomics, and personalized medicine research potentiates the demand for media storage equipment. Government bodies provide funding for biomedical research. The segmental growth is also attributed to the growing pipelines of biopharmaceuticals.
The clinical applications segment is expected to gain the highest market share between 2026 and 2035, driven by cell-based therapy and fertility treatment implementation. Blood, plasma, and transplant materials are complex materials that demand sophisticated storage facilities at hospitals and specialty clinics. The demand is stimulated by the growing number of organ transplants and immunotherapy. Growth is further encouraged by the development of cord blood banks and IVF centres. The tough regulatory standards of clinical-grade storage increase the need for equipment upgrades.
End-Use Insights
Which End-Use Segment Led the Biopreservation Media Storage Equipment Market?
The healthcare industry segment accounted for the highest market share in 2025, as storage systems are used on a large-scale in hospitals, blood banks, and transplant centres. The increasing number of surgeries and chronic diseases, and the growing need for preserved biological material, are becoming more significant. Good equipment is embraced by well-developed areas with strong infrastructure. The need to control infection and maintain regulatory compliance also fosters investment in credible storage systems. Continuous modernization of hospital laboratories also fosters the segment's growth.
The biotechnology segment is expected to witness the fastest growth in the market over the forecast period, driven by a fast pace of biologics and gene therapies. Biotech companies need high-tech cryogenic technology in clinical trials and product development. The increase in venture capital investment in biotech startups facilitates the growth of infrastructure. The rising cooperation between biotech businesses and research centres is driving a higher demand for equipment. The increasing commercialization of cell and gene therapies also contributes to the segment's growth.
Regional Analysis
Why North America Dominated the Market?
North America held a major revenue share of the biopreservation media storage equipment market in 2025 because of the highly developed healthcare infrastructure and rising investments in R&D. The region is home to many biobanks, pharmaceutical firms, and research centres. Embracing of cell and gene therapies is high, and this creates the need to have controlled storage methods. Biomedical innovation is also supported by the government, which is a factor that helps in market expansion. Competent regulatory standards provide compliance with quality and safety. Cold chain systems are technologically ahead of their time, which promotes regional supremacy.
Country-Level Analysis
At the national level, the U.S. is a leader due to the expansive biotechnology sector and massive healthcare expenditure. Canada is making contributions in the form of increasing research facilities and publicly funded healthcare programs. The U.S. has a good representation of major equipment manufacturers. The growing domestic demand is a result of the growing research into stem cells and clinical trials. Favourable reimbursement schemes also propel market growth.
How is Asia-Pacific Growing in the Market?
Asia-Pacific is expected to experience the fastest growth in the biopreservation media storage equipment market during the predicted timeframe, as a result of the growing healthcare infrastructure and the rising clinical research processes. The increasing population and the escalating chronic disease burden provoke the demand for preserved biological samples.
Government programs make constant efforts to improve the production of biopharmaceuticals within the country improve market potential. Adoption is also encouraged by rapid urbanization and increased spending on healthcare. The demand for equipment is influenced by the growth of fertility clinics and stem cell banking. When there is an influx of foreign investments in life sciences, development is quicker.
Country-Level Analysis
On the national scale, China is the growth leader of the region due to huge biotechnological and pharmaceutical production investments. India has good prospects of growing networks of hospitals and research centres. Japan has a consistent demand due to the use of high medical technology. Innovative medicine in regeneration has its input in South Korea. Gradual improvements in laboratory infrastructure are being witnessed in Southeast Asian countries.
Will Europe Grow in the Biopreservation Media Storage Equipment Market?
Europe is expected to grow at a notable CAGR in the foreseeable future, due to the increase in investments in life sciences research and regenerative medicine. The increase in pharmaceutical production capacity leads to the amplification of storage systems. Good regulatory systems are used to handle biological materials in a safe manner. Modernization of healthcare through government-sponsored programs encourages the updating of equipment. The increase in organ transplantation and fertility treatment volumes also increases adoption.
Country-Level Analysis
Germany is the country-level leader in the market as it has a high base of biomedical research and hospital infrastructure. The steady growth of France and the United Kingdom is backed by publicly financed healthcare systems. Investments in the modernization of laboratories are growing in Italy and Spain. Northern nations focus on high-quality standards of biobanking. Eastern Europe is slowly ramping up research capabilities in healthcare. Together, these processes are the driving force of the fast developmental process of Europe.
Biopreservation Media Storage Equipment Market Value Chain Analysis
Biopreservation Media Storage Equipment Market Companies
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Azenta, Inc.
- BioLife Solutions Inc.
- PHC Holdings Corporation
- Cryoport Systems, LLC
- Sartorius AG
- Avantor, Inc.
- Eppendorf SE
- Haier Biomedical Chart Industries, Inc.
- Bio-Techne Corporation
- STEMCELL Technologies, Inc.
- ThermoGenesis Holdings, Inc.
- Helmer Scientific Inc.
- Stirling Ultracold
- IC Biomedical, LLC
Top Companies and Their Offerings
| Company | Product launch | Aim | Prospects |
| Haier biomedical | Cryobio LN, storage series and wide-neck | Enhances the storage access with an intelligent system monitoring process. | Strengthen position in biobanking and clinical labs. |
| Cryoport Inc | T-90 LN storage freezer | Deliver reliable, compressor-free LN storage with precise control | Grow presence in research labs and fertility centres with energy-efficient systems |
| GenFollower | High-performance cryogenic storage boxes | Improve cryogenic sample organization and durability. | Expand into the consumable segment to support high throughout biobanks. |
| Cole-Parmer | PolarSafe, Storage Dewar, TraceableLIVE Bundle | Integrated storage with real-time logging and remote monitoring | Strengthen smart storage offerings and data-driven cold chain. |
Recent Developments
- In February 2026, Cryoport, Inc. announced the launch of MVE Fusion 800 Series, an advanced line of cryogenic storage systems. This new series features improved insulation, increased storage capacity, and enhanced temperature stability, making it ideal for the biopharmaceutical and life sciences sectors. The freezer delivers exceptional reliability, safety, and sustainability for space-constrained environments.(source: https://www.prnewswire.com)
- In February 2026, CaseBioscience announced the launch of CaseCryo CTG DMSO, a next-generation cryopreservation solution to support clinical cell therapy development. The company also aims to launch the CaseStor HSS Hypothermic Storage Solution for the controlled hypothermic storage of cells and tissues. (Source: https://www.prnewswire.com)
- In December 2025, Haier Biomedical launched its next-generation CryoBio LN2 storage systems, designed for ultra-low temperature preservation of biological samples. These systems enhance performance with improved insulation and energy efficiency, addressing the needs of biobanks and research institutions for a secure and reliable storage solution.(source: https://www.scientistlive.com)
- In April 2025, BioLife Solutions, Inc. announced that it acquired PanTHERA CryoSolutions, Inc. to strengthen BioLife's position in the biopreservation market, enhancing its product portfolio of consumable solutions and adding scientific capabilities to the management team. PanTHERA's differentiated IRI technology enhances the core capabilities in biopreservation. (Source: https://www.prnewswire.com)
Segments Covered in the Report
By Product Type
- Cryopreservation Equipment
- Controlled-Rate Freezers
- Liquid Nitrogen Storage Tanks
- Others
By Application
- Research & Development
- Clinical Applications
- Commercial Applications.
By End-Use
- Healthcare
- Biotechnology
- Academic Research
By Region
- North America
- Latin America
- Europe
- Asia-pacific
- Middle and East Africa
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
Frequently Asked Questions
Ask For Sample
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
sales@precedenceresearch.com
+1 804-441-9344
Schedule a Meeting